Comment
doi: 10.1056/NEJMp048016.
CGRP-receptor antagonists--a fresh approach to migraine therapy?
Affiliations
- PMID: 15014178
- DOI: 10.1056/NEJMp048016
Item in Clipboard
Comment
CGRP-receptor antagonists--a fresh approach to migraine therapy?
N Engl J Med.
.
No abstract available
Comment on
-
Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine.N Engl J Med. 2004 Mar 11;350(11):1104-10. doi: 10.1056/NEJMoa030505. N Engl J Med. 2004. PMID: 15014183 Clinical Trial.
Similar articles
-
CGRP receptors: a headache to study, but will antagonists prove therapeutic in migraine?Trends Pharmacol Sci. 2002 Feb;23(2):51-3. doi: 10.1016/s0165-6147(02)01945-4. Trends Pharmacol Sci. 2002. PMID: 11830255 No abstract available.
-
CGRP receptor antagonists: a new choice for acute treatment of migraine?Curr Opin Investig Drugs. 2004 Jul;5(7):731-5. Curr Opin Investig Drugs. 2004. PMID: 15298069 Review.
-
The tortuous road to an ideal CGRP function blocker for the treatment of migraine.Curr Top Med Chem. 2008;8(16):1468-79. doi: 10.2174/156802608786264218. Curr Top Med Chem. 2008. PMID: 18991732 Review.
-
[Recent development of calcitonin gene-related peptide (CGRP) receptor antagonist].Nihon Rinsho. 2005 Oct;63 Suppl 10:263-6. Nihon Rinsho. 2005. PMID: 16279645 Review. Japanese. No abstract available.
-
Efficacy of the non-peptide CGRP receptor antagonist BIBN4096BS in blocking CGRP-induced dilations in human and bovine cerebral arteries: potential implications in acute migraine treatment.Neuropharmacology. 2002 Mar;42(4):568-76. doi: 10.1016/s0028-3908(02)00008-4. Neuropharmacology. 2002. PMID: 11955527
Cited by
-
Understanding migraine: Potential role of neurogenic inflammation.Ann Indian Acad Neurol. 2016 Apr-Jun;19(2):175-82. doi: 10.4103/0972-2327.182302. Ann Indian Acad Neurol. 2016. PMID: 27293326 Free PMC article. Review.
-
Current and prospective pharmacological targets in relation to antimigraine action.Naunyn Schmiedebergs Arch Pharmacol. 2008 Oct;378(4):371-94. doi: 10.1007/s00210-008-0322-7. Epub 2008 Jul 15. Naunyn Schmiedebergs Arch Pharmacol. 2008. PMID: 18626630 Review.
-
Raynaud's phenomenon secondary to erenumab in a patient with chronic migraine.Clin Case Rep. 2021 Aug 16;9(8):e04625. doi: 10.1002/ccr3.4625. eCollection 2021 Aug. Clin Case Rep. 2021. PMID: 34430000 Free PMC article.
-
Modelling the anti-migraine effects of BIBN 4096 BS: a new calcitonin gene-related peptide receptor antagonist.Clin Pharmacokinet. 2006;45(7):715-28. doi: 10.2165/00003088-200645070-00006. Clin Pharmacokinet. 2006. PMID: 16802852 Clinical Trial.
-
Capsaicin, The Vanilloid Receptor TRPV1 Agonist in Neuroprotection: Mechanisms Involved and Significance.Neurochem Res. 2023 Nov;48(11):3296-3315. doi: 10.1007/s11064-023-03983-z. Epub 2023 Jul 26. Neurochem Res. 2023. PMID: 37493882 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
